NewAmsterdam Pharma Company N.V — Balance Sheet (NASDAQ:NAMS) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets —347.1 M864.62 M769.28 M Total liabilities —58.7 M107.12 M85.85 M Total equity —288.39 M757.5 M683.43 M Total liabilities & shareholders' equities —347.1 M864.62 M769.28 M Total debt ———— Net debt ————

ニュース

Cantor Fitzgerald、NewAmsterdam Pharma株の投資判断をOverweightで継続

Cantor Fitzgerald reiterates NewAmsterdam Pharma stock rating at Overweight

Guggenheim、EU発売時期を理由にNewAmsterdam Pharma目標株価を引き上げ

Guggenheim raises NewAmsterdam Pharma stock price target on EU launch timing

【決算速報】NewAmsterdam Pharma、売上高は予想を下回り、利益は予想を下回る結果に

NewAmsterdam Pharma earnings missed by $0.23, revenue fell short of estimates

NewAmsterdamがコレステロール薬の欧州医薬品庁決定を2026年後半に期待

NewAmsterdam expects EMA decision on cholesterol drug in second half 2026

リアリンク・パートナーズ、NewAmsterdam Pharmaの目標株価を55ドルに引き上げ

NewAmsterdam Pharma stock price target raised to $55 by Leerink Partners

パイパー・サンドラーが2026年に注目すべき商業バイオテクノーム企業を発表

Piper Sandler highlights commercial biotech names to own in 2026